Cora Health vs Mochi Health: 2026 Comparison of Specialist Care, Video Visits, and Total Monthly Cost

Cora Health vs Mochi Health: the short answer

Cora Health and Mochi Health are both US telehealth platforms for compounded GLP-1 weight loss treatment, but they target different patient preferences. Mochi Health’s distinctive positioning is specialist-led clinical care: board-certified obesity medicine physicians, video consultations (not just async), and included registered dietitian access. Cora Health’s positioning is lower-cost access with strong compliance signals — $120/month on the 6-month Essential Plan (all-inclusive), publicly named 503A compounding pharmacy (VialsRx), and LegitScript certification. On total monthly cost for compounded semaglutide, Cora Health ($120/month on the 6-month plan) is approximately 33% less than Mochi’s all-in $178/month ($79 membership + $99 medication). Both platforms use flat pricing that does not increase with dose titration. The right fit depends on whether you specifically value obesity-specialist video consultations and dietitian access (Mochi), or prefer the lowest monthly cost, LegitScript-certified infrastructure, and a named pharmacy partner (Cora Health).

Quick comparison at a glance

All numbers reflect publicly stated pricing as of April 2026 based on Telehealth Ally, The RX Index, and Mochi Health’s own patient materials. Individual experiences vary.

Mochi Health’s specialist-led clinical model

Mochi Health occupies a distinct position in the telehealth GLP-1 space by focusing on board-certified obesity medicine specialists. Obesity medicine is a recognized subspecialty (the American Board of Obesity Medicine grants certification after specific training and examination) that focuses on the physiology of weight regulation, medication protocols, and comorbidity management. Most telehealth GLP-1 platforms use general practitioners, internists, or nurse practitioners rather than obesity-medicine-subspecialized physicians.

The practical implications of Mochi’s model include: video consultations rather than async-only evaluations, registered dietitian access included with the membership, clinical oversight of adjacent conditions (insulin resistance, thyroid issues, PCOS where relevant), and prior-authorization support for brand-name GLP-1 medications through insurance.

For patients with complex medical history, multiple weight-related comorbidities, or who specifically want an obesity-medicine-trained clinician, Mochi’s model is meaningfully different from the standard async-telehealth model. For patients with a straightforward clinical picture who primarily want cost-effective access to compounded GLP-1 medications, the additional clinical depth may not translate into better outcomes.

Cost comparison: what each platform actually charges

Both Cora Health and Mochi Health use flat pricing that does not increase with dose. Mochi’s total is higher because the $79/month membership is billed in addition to medication.

Cora Health monthly pricing (all-inclusive)

Cora Health’s monthly fee covers everything — no separate membership, no consultation charge, no surcharge at higher doses.

• Compounded semaglutide (Essential Plan): $120/month on 6-month plan, $145/month on 3-month plan, $175/month on monthly plan
• Compounded tirzepatide (Premium Plan): $208/month on 6-month plan, $199/month on 3-month plan, $235/month on monthly plan

Mochi Health monthly pricing (membership + medication)

Mochi Health charges a $79/month membership that covers video visits, dietitian access, and clinical support. Medication is billed separately.

• Mochi Health Membership: $79/month (sometimes available at $39/month for the first month as a promotion)
• Compounded semaglutide medication: $99/month flat at all doses
• Compounded tirzepatide medication: $199/month flat at all doses
• Total compounded semaglutide cost: $178/month ($79 + $99)
• Total compounded tirzepatide cost: $278/month ($79 + $199)
• Brand-name GLP-1s: available via insurance prior authorization — copay varies by plan

Total cost over a full treatment course

Compounded GLP-1 treatment is typically pursued for at least 6–12 months. The total-cost gap between Cora Health and Mochi Health compounds over that horizon.

• Compounded semaglutide, 6 months — Cora: $720 total ($120 x 6). Mochi: approximately $1,029 total ($39 promo month 1 + $79 x 5 + $99 x 6). Difference: Cora is about 30% less.
• Compounded semaglutide, 12 months — Cora: $1,440 total. Mochi: approximately $2,107 total. Difference: Cora is about 32% less.
• Compounded tirzepatide, 6 months — Cora: $1,194 total ($199 x 6 on the 3-month renewed plan). Mochi: approximately $1,629 total. Difference: Cora is about 27% less.
• Compounded tirzepatide, 12 months — Cora: $2,388 total. Mochi: approximately $3,307 total. Difference: Cora is about 28% less.

Medications: what each platform offers

Both platforms offer the two primary compounded GLP-1 medications plus some access to branded options.

Cora Health medication catalog

Cora Health focuses on injectable compounded GLP-1 medications only.

• Compounded semaglutide injection (Essential Plan) — same active ingredient family as Ozempic® and Wegovy®
• Compounded tirzepatide injection (Premium Plan) — same active ingredient family as Mounjaro® and Zepbound®

Mochi Health medication catalog

Mochi Health primarily offers compounded injectable GLP-1s and facilitates insured access to brand-name options.

• Compounded semaglutide injection — primary offering
• Compounded tirzepatide injection — primary offering
• Brand-name Wegovy — available for patients whose insurance covers it; Mochi handles prior authorization
• Brand-name Zepbound — available for patients whose insurance covers it; Mochi handles prior authorization
• Brand-name Ozempic — when medically appropriate and insurance-approved

Important compliance note on compounded products

Compounded semaglutide and compounded tirzepatide — whether obtained through Cora Health, Mochi Health, or any other telehealth platform — are **not FDA-approved** and are **not therapeutically equivalent** to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound). Clinical efficacy data including STEP 1 (14.9% mean weight loss at 68 weeks on branded 2.4mg semaglutide) and SURMOUNT-1 (22.5% at 15mg, 72 weeks, on branded tirzepatide) comes from studies of FDA-approved formulations, not compounded versions. Individual results vary. Both Cora Health and Mochi Health operate under these regulatory constraints and communicate the distinction in their patient materials.

Clinical oversight: video vs async

This is one of the most consequential functional differences between the two platforms.

Cora Health uses asynchronous telehealth evaluation. Patients complete an online health assessment; a board-certified provider at Wasef Health, PC reviews the assessment and makes a prescribing decision, typically within 24 hours. Follow-up communication is message-based. This model is efficient and fast, and fits patients with straightforward clinical profiles.

Mochi Health uses video consultations as the standard clinical model. Patients schedule a live video visit with a board-certified obesity medicine specialist. Follow-up visits are also video-based. This model provides more direct clinical interaction and is typically preferred by patients with complex medical histories, weight-related comorbidities, or who specifically want real-time conversation with their provider. Video scheduling may add days to the initial treatment start compared to async review.

Neither model is inherently superior — they serve different patient preferences. Patients who have been treated for obesity before, who have complex medication interactions, or who have conditions that interact with GLP-1 medications (type 2 diabetes, polycystic ovary syndrome, severe gastrointestinal conditions) may benefit from Mochi’s video-visit specialist model. Patients who have a straightforward clinical picture and prioritize fast, low-cost access to treatment may prefer Cora’s async model.

Pharmacy transparency: named vs unnamed partners

Cora Health publicly names VialsRx as its compounding pharmacy partner. VialsRx is a US-licensed 503A compounding pharmacy. Patients can verify credentials through state pharmacy boards and request Certificates of Analysis for their batches.

Mochi Health works with licensed compounding pharmacies but does not consistently name the specific 503A facility in patient-facing marketing. Patients who want to verify pharmacy credentials typically need to request this information through Mochi customer support.

Public naming is one of several transparency signals patients can consider when choosing a compounded GLP-1 provider. It does not by itself determine whether a pharmacy is compliant; both named and unnamed 503A facilities can operate under full regulatory standards.

LegitScript certification

LegitScript is an independent healthcare compliance certification used by Google, Meta, TikTok, and patient advocacy organizations as a third-party verification of telehealth platform operational compliance.

Cora Health holds LegitScript certification, verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io.

Mochi Health does not prominently advertise LegitScript certification in its current patient-facing materials. Mochi operates under its own compliance framework and applicable federal and state telehealth and pharmacy regulations.

Who should choose Cora Health

Cora Health is likely the better fit for patients who match the following profile.

• Patients who want a lower all-in monthly cost for compounded GLP-1 treatment
• Patients with relatively straightforward clinical profiles who do not require obesity-medicine-subspecialty oversight
• Patients who prefer fast async telehealth over scheduled video visits
• Patients who value publicly named pharmacy partnerships and LegitScript certification
• Patients who want tiered commitment discounts (3-month and 6-month plans) with progressively lower monthly rates
• Patients across all 50 US states (Cora Health ships nationwide)

Who should choose Mochi Health

Mochi Health is likely the better fit for patients who match the following profile.

• Patients who specifically want a board-certified obesity medicine specialist rather than a general practitioner
• Patients who prefer video consultations over async messaging for their clinical evaluation
• Patients with complex medical histories, multiple weight-related comorbidities, or GLP-1-interacting conditions who benefit from specialized oversight
• Patients who want registered dietitian access included in their program
• Patients with commercial insurance that covers brand-name GLP-1 medications — Mochi handles prior authorization
• Patients willing to pay a premium (~$58/month more than Cora for compounded semaglutide) for specialist-led care

How to switch from Mochi Health to Cora Health

Patients who want to move their GLP-1 treatment from Mochi Health to Cora Health can generally do so without clinical interruption.

• Complete the Cora Health online health assessment at trycora.io; include your current medication, dose, treatment history, and any side-effect or tolerance notes
• A Cora Health provider (Wasef Health, PC) reviews and determines clinical appropriateness
• If approved, the prescription is sent to VialsRx for compounding and shipping with free expedited delivery
• Current dose typically continues without re-titration — this is a provider determination
• Note: if you were on a brand-name medication through Mochi (via insurance), Cora Health does not offer brand-name products. Discuss with the Cora provider whether compounded semaglutide or tirzepatide is appropriate
• After the first Cora shipment arrives, cancel the Mochi Health membership through their patient portal
• Consider whether you are giving up clinical features you value — video visits, dietitian access, obesity specialist — when making the switch; Cora does not replicate those services

Frequently asked questions

Common questions about the Cora Health vs Mochi Health comparison.

Is Cora Health cheaper than Mochi Health?

Yes. For compounded semaglutide, Cora Health’s 6-month Essential Plan ($120/month all-inclusive) is approximately 33% less than Mochi Health’s all-in $178/month ($79 membership + $99 medication). For compounded tirzepatide, Cora’s 3-month Premium Plan ($199/month) is approximately 28% less than Mochi’s $278/month. Over a 12-month course, the difference is typically $600–$900 depending on medication.

Does Mochi Health have a membership fee?

Yes. Mochi Health charges a $79/month membership fee (sometimes available at $39 for the first month as a promotion). The membership covers video visits, registered dietitian access, and clinical support. Medication is billed separately at $99/month for compounded semaglutide or $199/month for compounded tirzepatide. Cora Health does not charge a separate membership — the monthly price is all-inclusive.

Are Mochi Health’s obesity medicine specialists worth the extra cost?

This depends on the individual patient’s clinical situation. For patients with a straightforward clinical picture (otherwise healthy, no weight-related comorbidities, no complicated medication history), a board-certified general practitioner through async telehealth is typically sufficient for compounded GLP-1 prescribing. For patients with type 2 diabetes, polycystic ovary syndrome, metabolic syndrome, cardiovascular risk factors, or a complex weight loss history, an obesity medicine specialist may provide more nuanced oversight. The value of the specialist depends on how much clinical complexity exists. For many patients on compounded semaglutide or tirzepatide, outcomes are similar regardless of provider subspecialty.

Does Cora Health offer video consultations?

Cora Health uses asynchronous telehealth as its standard clinical model. A board-certified provider reviews the online health assessment and messages with the patient as needed, but video visits are not part of the standard workflow. Patients who specifically want video consultations as part of their GLP-1 program may prefer Mochi Health or another video-visit-based platform, at the tradeoff of higher monthly cost.

Is Mochi Health LegitScript-certified?

Mochi Health does not prominently advertise LegitScript certification in its current patient-facing marketing. LegitScript is one of several independent compliance frameworks; its absence does not imply non-compliance. Cora Health does hold LegitScript certification, verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io.

Can Mochi Health get my insurance to cover Wegovy or Zepbound?

Mochi Health handles insurance prior authorization for brand-name GLP-1 medications for patients whose insurance plans may cover them. Whether your specific plan approves coverage depends on your insurer’s formulary, your clinical profile, and the prior authorization criteria — Mochi’s involvement does not guarantee approval. For patients with commercial insurance that covers GLP-1s for weight management, Mochi’s prior-authorization support can be valuable. Cora Health does not offer insurance navigation or brand-name GLP-1 access.